8.700
+0,12%
2026-10-19
Fundamental Analysis
78 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +1053.5% | +367.7% | 2 / 3 | +47.3% | +1.52 pp | +2.14 pp | +6.0% | 0.00 | 10.23 | 2.858 | +47,3% | 70,3 | +1.053,5% | 10.23 | 10.20 | +0,3% |
| Pts | 12 | 12 | 8 | 12 | 8 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 8.700 (close price on 2026-10-19)EPS (TTM): 850,7
Financial charts
1.Revenue & growth
VND bn2.858Q2/26
1.Revenue & growth
VND bn2.858Q2/26
2.Profit & growth
VND bn70,3Q2/26
3.Profit mix (Penman)
VND bn304Q2/26
4.Margins & cost structure
%3.4%Q2/26
5.Returns & cash cycle
% · days2.9%Q2/26
6.Earnings quality & cash
VND bn37,7Q2/26
7.Asset structure
VND bn6.057Q2/26
8.Funding & debt health
VND bn · times6.057Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %10,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %215Q2/26
Adjusted EPS growth, latest quarter
11,5× higher
Average adjusted EPS growth, 3 quarters
368%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26